EcoDrugPlus

Ribosomal Protein S6 Kinase B1

Ensembl ID : ENSDLAG00005013888
Gene Symbol: RPS6KB1
1 Cross references
223 Possible Orthologues:

Selectin E

Ensembl ID : ENSDLAG00005002251
Gene Symbol: SELE
1 Cross references
181 Possible Orthologues:

Selectin P

Ensembl ID : ENSDLAG00005002264
Gene Symbol: SELP
1 Cross references
170 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSDLAG00005030137
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSDLAG00005008329
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
203 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSDLAG00005020945
Gene Symbol: SMO
1 Cross references
204 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 10

Ensembl ID : ENSDLAG00005023531
Gene Symbol: SCN10A
1 Cross references
245 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSDLAG00005032437
Gene Symbol: SLC10A2
1 Cross references
211 Possible Orthologues:

Solute Carrier Family 18 Member 2

Ensembl ID : ENSDLAG00005011313
Gene Symbol: SLC18A2
1 Cross references
216 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSDLAG00005022301
Gene Symbol: SLC5A2
1 Cross references
199 Possible Orthologues:

Solute Carrier Family 6 Member 1a

Ensembl ID : ENSDLAG00005004349
Gene Symbol: SLC6A1A
1 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 1b

Ensembl ID : ENSDLAG00005007430
Gene Symbol: SLC6A1B
1 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).